|
2025-04-09 |
2025-04-08 |
B
Purchase
|
McArthur James G
President and CEO
Executive Director
|
1,000
+66.5%
1.15
USD 47,725
|
1,000
+66.5%
|
1.15
|
USD 100,000
|
|
|
2025-02-26 |
2025-02-26 |
PS
Planned sale
|
DeLena Mary Beth
General Counsel
Officer
|
1,432
-47.7%
1.68
USD 2,406
|
1,432
-47.7%
|
1.68
|
USD 2,406
|
|
|
2025-02-26 |
2025-02-26 |
PS
Planned sale
|
Donnelly Noel
Chief Financial Officer
Officer
|
1,527
-47.7%
1.68
USD 2,565
|
1,527
-47.7%
|
1.68
|
USD 2,565
|
|
|
2024-07-26 |
2024-07-25 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
7,571
-100.0%
18.06
USD 136,741
|
7,571
-100.0%
|
18.06
|
USD 136,741
|
|
|
2024-07-26 |
2024-07-24 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
201
-100.0%
18.01
USD 3,619
|
201
-100.0%
|
18.01
|
USD 3,619
|
|
|
2024-07-19 |
2024-07-18 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
12,625
-100.0%
18.20
USD 229,804
|
12,625
-100.0%
|
18.20
|
USD 229,804
|
|
|
2024-07-16 |
2024-07-16 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
5,901
-100.0%
18.00
USD 106,247
|
5,901
-100.0%
|
18.00
|
USD 106,247
|
|
|
2024-07-16 |
2024-07-12 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
3,288
-100.0%
18.04
USD 59,331
|
3,288
-100.0%
|
18.04
|
USD 59,331
|
|
|
2024-07-03 |
2024-07-02 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
37
-100.0%
18.07
USD 669
|
37
-100.0%
|
18.07
|
USD 669
|
|
|
2024-07-03 |
2024-07-01 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
875
-100.0%
18.01
USD 15,760
|
875
-100.0%
|
18.01
|
USD 15,760
|
|
|
2024-06-26 |
2024-06-24 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
9,260
-100.0%
18.19
USD 168,427
|
9,260
-100.0%
|
18.19
|
USD 168,427
|
|
|
2024-06-13 |
2024-06-12 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
1,086
-100.0%
18.06
USD 19,615
|
1,086
-100.0%
|
18.06
|
USD 19,615
|
|
|
2024-06-13 |
2024-06-11 |
PS
Planned sale
|
Mellion Michelle L
Chief Medical Officer
Officer
|
500
-100.0%
18.04
USD 9,022
|
500
-100.0%
|
18.04
|
USD 9,022
|
|
|
2024-06-07 |
2024-06-06 |
PS
Planned sale
|
Mellion Michelle L
SVP, Clinical Development
Officer
|
1,411
-100.0%
18.00
USD 25,398
|
1,411
-100.0%
|
18.00
|
USD 25,398
|
|
|
2024-06-07 |
2024-06-05 |
PS
Planned sale
|
Mellion Michelle L
SVP, Clinical Development
Officer
|
7,245
-100.0%
18.09
USD 131,062
|
7,245
-100.0%
|
18.09
|
USD 131,062
|
|
|
2024-05-17 |
2024-05-17 |
PS
Planned sale
|
Svenstrup Niels
SVP, Chem. Mfg & Controls
Officer
|
10,000
-100.0%
13.41
USD 134,100
|
10,000
-100.0%
|
13.41
|
USD 134,100
|
|
|
2024-02-13 |
2024-02-09 |
B
Purchase
|
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
Large shareholder
|
2,557,593
+38.6%
10.64
USD 27,212,790
|
2,557,593
+38.6%
|
10.64
|
USD 27,212,790
|
|
|
2023-12-05 |
2023-11-30 |
PP
Planned purchase
|
McArthur James G
President and CEO
Executive Director
|
1,694
+inf%
4.17
USD 7,056
|
1,694
+inf%
|
4.17
|
USD 7,056
|
|
|
2023-06-09 |
2023-06-08 |
PS
Planned sale
|
McArthur James G
President and CEO
Executive Director
|
2,381
-100.0%
16.04
USD 38,188
|
2,381
-100.0%
|
16.04
|
USD 38,188
|
|
|
2023-06-08 |
2023-06-07 |
PS
Planned sale
|
McArthur James G
President and CEO
Executive Director
|
8,419
-100.0%
16.23
USD 136,618
|
8,419
-100.0%
|
16.23
|
USD 136,618
|
|
|
2023-06-08 |
2023-06-06 |
PS
Planned sale
|
McArthur James G
President and CEO
Executive Director
|
18,150
-100.0%
16.18
USD 293,660
|
18,150
-100.0%
|
16.18
|
USD 293,660
|
|
|
2023-06-06 |
2023-06-05 |
PS
Planned sale
|
McArthur James G
President and CEO
Executive Director
|
500
-100.0%
16.06
USD 8,028
|
500
-100.0%
|
16.06
|
USD 8,028
|
|
|
2023-06-06 |
2023-06-02 |
PS
Planned sale
|
McArthur James G
President and CEO
Executive Director
|
1,800
-100.0%
16.04
USD 28,863
|
1,800
-100.0%
|
16.04
|
USD 28,863
|
|
|
2023-03-28 |
2023-03-24 |
PS
Planned sale
|
Goyal Jaya
EVP, Res. & Preclin. Dev.
Officer
|
392
-100.0%
20.00
USD 7,840
|
392
-100.0%
|
20.00
|
USD 7,840
|
|
|
2023-02-08 |
2023-02-08 |
PS
Planned sale
|
Goyal Jaya
EVP, Res. & Preclin. Dev.
Officer
|
644
-100.0%
17.00
USD 10,948
|
644
-100.0%
|
17.00
|
USD 10,948
|
|
|
2023-02-08 |
2023-02-07 |
PS
Planned sale
|
Goyal Jaya
EVP, Res. & Preclin. Dev.
Officer
|
3,679
-100.0%
17.18
USD 63,213
|
3,679
-100.0%
|
17.18
|
USD 63,213
|
|
|
2023-02-08 |
2023-02-06 |
PS
Planned sale
|
Goyal Jaya
EVP, Res. & Preclin. Dev.
Officer
|
1,677
-100.0%
17.04
USD 28,568
|
1,677
-100.0%
|
17.04
|
USD 28,568
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
Large shareholder
|
249,749
+23.7%
12.00
USD 2,996,988
|
249,749
+23.7%
|
12.00
|
USD 2,996,988
|
|
|
2022-05-12 |
2022-05-10 |
B
Purchase
|
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
Large shareholder
|
2,979,451
+81.8%
12.00
USD 35,753,412
|
2,979,451
+81.8%
|
12.00
|
USD 35,753,412
|
|
|
2022-05-10 |
2022-05-10 |
B
Purchase
|
Flynn James E
Large shareholder
|
208,333
+77.6%
12.00
USD 2,499,996
|
208,333
+77.6%
|
12.00
|
USD 2,499,996
|
|
|
2022-05-10 |
2022-05-10 |
B
Purchase
|
Flynn James E
Large shareholder
|
208,333
+77.6%
12.00
USD 2,499,996
|
208,333
+77.6%
|
12.00
|
USD 2,499,996
|
|
|
2023-01-19 |
2022-05-06 |
B
Purchase
|
KEATING LAURIE
Non-Executive Director
|
4,166
+inf%
12.00
USD 49,992
|
4,166
+inf%
|
12.00
|
USD 49,992
|
|
